Grisnilimab, CAS 2367001-70-3

Product Description: Grisnilimab (WT1), a IgG2a monoclonal antibody anti-CD7, is a tumor suppressor involved in the etiology of Wilms' tumor. Grisnilimab regulates the transcription of multiple target genes and may participate in the post-transcriptional processing of RNA[1].

Applications: Cancer-programmed cell death

Formula: N/A

References: [1]Scharnhorst V, et al. WT1 proteins: functions in growth and differentiation. Gene. 2001 Aug 8;273(2):141-61./[2]Hertler AA, et al. An immunotoxin for the treatment of T-acute lymphoblastic leukemic meningitis: studies in rhesus monkeys. Cancer Immunol Immunother. 1989;28(1):59-66.

CAS Number: 2367001-70-3

Molecular Weight: N/A

Compound Purity: 97.34

Research Area: Cancer

Solubility: 10 mM in DMSO

Target: Others

• SKU: MEXHY-P99650-10
• Manufacturer: MedChemExpress
• Manufacturer SKU: HY-P99650-10
• Package Unit: 10 mg
• Quantity Unit: STK
• Conjugate: Unconjugated